Genetics and Genetic Testing in Congenital Heart Disease

Jason R. Cowan, Stephanie Ware

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Congenital heart defects (CHDs) are structural abnormalities of the heart and great vessels that are present from birth. The presence or absence of extracardiac anomalies has historically been used to identify patients with possible monogenic, chromosomal, or teratogenic CHD causes. These distinctions remain clinically relevant, but it is increasingly clear that nonsyndromic CHDs can also be genetic. This article discusses key morphologic, molecular, and signaling mechanisms relevant to heart development, summarizes overall progress in molecular genetic analyses of CHDs, and provides current recommendations for clinical application of genetic testing.

Original languageEnglish
Pages (from-to)373-393
Number of pages21
JournalClinics in Perinatology
Volume42
Issue number2
DOIs
StatePublished - Jun 1 2015

Fingerprint

Congenital Heart Defects
Genetic Testing
Heart Diseases
Molecular Biology
Parturition

Keywords

  • Cardiovascular malformation
  • Congenital anomaly
  • Development
  • Genetic counseling
  • Genetic testing
  • Genetics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Genetics and Genetic Testing in Congenital Heart Disease. / Cowan, Jason R.; Ware, Stephanie.

In: Clinics in Perinatology, Vol. 42, No. 2, 01.06.2015, p. 373-393.

Research output: Contribution to journalArticle

@article{611d524663fa4ffc9c79439de6930c54,
title = "Genetics and Genetic Testing in Congenital Heart Disease",
abstract = "Congenital heart defects (CHDs) are structural abnormalities of the heart and great vessels that are present from birth. The presence or absence of extracardiac anomalies has historically been used to identify patients with possible monogenic, chromosomal, or teratogenic CHD causes. These distinctions remain clinically relevant, but it is increasingly clear that nonsyndromic CHDs can also be genetic. This article discusses key morphologic, molecular, and signaling mechanisms relevant to heart development, summarizes overall progress in molecular genetic analyses of CHDs, and provides current recommendations for clinical application of genetic testing.",
keywords = "Cardiovascular malformation, Congenital anomaly, Development, Genetic counseling, Genetic testing, Genetics",
author = "Cowan, {Jason R.} and Stephanie Ware",
year = "2015",
month = "6",
day = "1",
doi = "10.1016/j.clp.2015.02.009",
language = "English",
volume = "42",
pages = "373--393",
journal = "Clinics in Perinatology",
issn = "0095-5108",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Genetics and Genetic Testing in Congenital Heart Disease

AU - Cowan, Jason R.

AU - Ware, Stephanie

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Congenital heart defects (CHDs) are structural abnormalities of the heart and great vessels that are present from birth. The presence or absence of extracardiac anomalies has historically been used to identify patients with possible monogenic, chromosomal, or teratogenic CHD causes. These distinctions remain clinically relevant, but it is increasingly clear that nonsyndromic CHDs can also be genetic. This article discusses key morphologic, molecular, and signaling mechanisms relevant to heart development, summarizes overall progress in molecular genetic analyses of CHDs, and provides current recommendations for clinical application of genetic testing.

AB - Congenital heart defects (CHDs) are structural abnormalities of the heart and great vessels that are present from birth. The presence or absence of extracardiac anomalies has historically been used to identify patients with possible monogenic, chromosomal, or teratogenic CHD causes. These distinctions remain clinically relevant, but it is increasingly clear that nonsyndromic CHDs can also be genetic. This article discusses key morphologic, molecular, and signaling mechanisms relevant to heart development, summarizes overall progress in molecular genetic analyses of CHDs, and provides current recommendations for clinical application of genetic testing.

KW - Cardiovascular malformation

KW - Congenital anomaly

KW - Development

KW - Genetic counseling

KW - Genetic testing

KW - Genetics

UR - http://www.scopus.com/inward/record.url?scp=84931563717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931563717&partnerID=8YFLogxK

U2 - 10.1016/j.clp.2015.02.009

DO - 10.1016/j.clp.2015.02.009

M3 - Article

C2 - 26042910

AN - SCOPUS:84931563717

VL - 42

SP - 373

EP - 393

JO - Clinics in Perinatology

JF - Clinics in Perinatology

SN - 0095-5108

IS - 2

ER -